Abstract
The molecular characterization of nonrandom recurrent cytogenetic abnormalities has identified numerous disease-related genes involved in hematologic and lymphoid malignancies. Cytogenetic analysis has become essential for disease diagnosis, classification, prognostic stratification, and treatment guidance. Fluorescence in situ hybridization (FISH) has greatly enhanced the field and enabled a more precise determination of the presence and frequency of genetic abnormalities. The advantages of FISH compared to standard cytogenetic analysis are that FISH can be used to identify genetic changes that are too small to be detected under a microscope, does not require cell culture, and can be applied directly on fresh or paraffin-embedded tissues for rapid evaluation of interphase nuclei. The application of FISH with a variety of chromosome-specific DNA probes helps to further define molecular subclasses and cytogenetic risk categories for patients with particular hematologic malignancies. FISH analysis is useful in identifying genetic abnormalities undetectable by conventional chromosomal analysis and monitoring residual disease during treatment and follow-up. Therefore, FISH has become an indispensable tool in the management of hematologic malignancies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Heim S, Mitelman F (eds) (2015) Cancer cytogenetics: chromosomal and molecular genetic aberrations of tumor cells, 4th edn. Wiley-Blackwell, New York
Rowley JD (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290–293. doi:10.1038/243290a0
Gozzetti A, Le Beau MM (2000) Fluorescence in situ hybridization: uses and limitations. Semin Hematol 37:320–333
Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951
Richkind K (2012) The role of classical cytogenetics in hematologic diagnosis. In: Davis BH, Kottke-Marchant K (eds) Laboratory hematology practice. Wiley-Blackwell, Oxford, UK
Wan TS, Ma ES (2011) Molecular cytogenetics: an indispensable tool for cancer diagnosis. Chang Gung Med J 35(2):96–110
Kolialexi A, Tsangaris GT, Kitsiou S et al (2005) Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies. Anticancer Res 25(4):2979–2983
Amiel A, Arbov L, Manor Y et al (1997) Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics. Cancer Genet Cytogenet 97(2):97–100
Schröck E, du Manoir S, Veldman T et al (1996) Multicolor spectral karyotyping of human chromosomes. Science 273:494–497
Kakazu N, Ashihara E, Hada S et al (2001) Development of spectral colour banding in cytogenetic analysis. Lancet 357:529–530. doi:10.1016/S0140-6736(00)04051-4
NCI and NCBI (2001) SKY/M-FISH and CGH Database (2001). http://www.ncbi.nlm.nih.gov/sky/skyweb.cgi
Schröck E, Padilla-Nash H (2000) Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations. Semin Hematol 37(4):334–347
Cuneo A, Bigoni R, Roberti MG et al (1997) Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization. Haematologica 82:85–90
Bishop R (2010) Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance. Biosci Horizons 3:85–95
Dewald GW, Schad CR, Christensen ER et al (1993) The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71(1):7–14
Chase A, Grand F, Zhang JG et al (1997) Factors influencing the false positive and negative rates of BCR‐ABL fluorescence in situ hybridization. Genes Chromosom Cancer 18(4):246–253
Kowalczyk JR, Gaworczyk A, Winnicka D et al (2003) Fluorescence in situ hybridization BCR/ABL fusion signal rate in interphase nuclei of healthy volunteer donors: a test study for establishing false positive rate. Cancer Genet Cytogenet 142(1):51–55
Primo D, Tabernero MD, Rasillo A et al (2003) Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL + leukemias: incidence and underlying genetic abnormalities. Leukemia 17:1124–1129. doi:10.1038/sj.leu.2402963
Volpi EV, Bridger JM (2008) FISH glossary: an overview of the fluorescence in situ hybridization technique. Biotechniques 45(4):385–386
van der Burg M, Beverloo HB, Langerak AW et al (1999) Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set. Leukemia 13(12):2107–2113
Shaffer LG (2001) Diagnosis of microdeletion syndromes by fluorescence in situ hybridization (FISH). Curr Protoc Hum. doi:10.1002/0471142905.hg0810s14
Test and Technology Transfer Committee, American College of Medical Genetics (2000) Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Genet Med 2:356–361
Wolff DJ, Bagg A, Cooley LD, The Association for Molecular Pathology Clinical Practice Committee and the American College of Medical Genetics Laboratory Quality Assurance Committee et al (2007) Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn 9(2):134–143. doi:10.2353/jmoldx.2007.060128
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Tansatit, M. (2017). Applications of Fluorescence In Situ Hybridization Technology in Malignancies. In: Wan, T. (eds) Cancer Cytogenetics. Methods in Molecular Biology, vol 1541. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6703-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6703-2_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6701-8
Online ISBN: 978-1-4939-6703-2
eBook Packages: Springer Protocols